TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Translational Development Acquisition Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.81−0.02 (-0.16%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Translational Development Acquisition has not reported a dividend
No dividend per share appears in Translational Development Acquisition's annual filings since fiscal 2022.